Background Cigarette smoking is one of the leading causes of early death. Varenicline
[Champix (UK), Pfizer Europe MA EEIG, Brussels, Belgium; or Chantix (USA), Pfizer Inc …

Background Tobacco smoking is one of the leading causes of deaths worldwide. Nearly one-
fifth of adults in the UK regularly smoke cigarettes. The ill-health associated with smoking …

Smoking is the leading preventable cause of morbidity and mortality in the US, and
decreasing smoking prevalence is a public health priority. Patients achieve the greatest …

Background Patients with type 2 diabetes (T2D) typically use several drug treatments during
their lifetime. There is a debate about the best second-line therapy after metformin …

Promoting smoking cessation is among the key medical interventions aimed at reducing
worldwide morbidity and mortality in this century. Both behavioural counselling and …

Aims To identify different types of models used in economic evaluations of smoking
cessation, analyse the quality of the included models examining their attributes and …

Abstract Objectives: The US Food and Drug Administration has expressed interest in using
mathematical models to evaluate potential tobacco policies. The goal of this systematic …

Aims Clinical smoking cessation interventions have been found typically to be highly cost‐
effective in many high‐income countries. There is a need to extend this to low‐and middle …

Aims To conduct a systematic review and meta‐analysis and pool the incremental net
benefits (INBs) of varenicline compared with behaviour support with bupropion or nicotine …

Background Smoking is probably the most important among preventable health risks. Health
economic evaluation of smoking-cessation interventions, applying a lifetime perspective, is …